Table 3.

Summary of clinical data in 28 patients with VP shunt infection

Case	Shunt removal	Causative pathogen	Antibody treatment (mg/kg/day)	Intrathecal therapy	Outcomes
1	No	klebsiella pneumoniae	Imipenem Amikacin	No	Died
2	Yes	klebsiella pneumoniae	Meropenem	Yes	Survival
3	Yes	klebsiella pneumoniae	Meropenem	No	Survival
4	Yes	S. epidermidis	Vancomycin Teicoplanin	Yes	Survival
5	No	S. aureus	Vancomycin Teicoplanin	No	Died
6	Yes	Pseudomonas aeruginosa	Rifampin	No	Survival
7	Yes	Pseudomonas maltophilia	Ceftazidime	No	Survival
8	Yes	acinetobacter baumannii	Imipenem Amikacin	No	Survival
9	Yes	enterobacter cloacae	Meropenem	No	Survival
10	Yes	S. aureus	Vancomycin	No	Survival
11	Yes	acinetobacter baumannii	Amikacin Fosfomycin	No	Died
12	No	acinetobacter baumannii	Meropenem	Yes	Survival
13	Yes	acinetobacter baumannii	Ceftazidime	No	Survival
14	Yes	coagulase-negative staphylococci	Vancomycin Gentamicin	Yes	Survival
15	Yes	S. epidermidis	Vancomycin	No	Survival
16	Yes	staphylococcus haemolyticus	Vancomycin Fosfomycin	No	Survival
17	Yes	S. aureus	Vancomycin	No	Survival
18	No	Pseudomonas maltophilia	Teicoplanin Rifampin	No	Died
19	Yes	Pseudomonas aeruginosa	Imipenem	No	Survival
20	No	negtive	Ceftazidime	No	Survival
21	Yes	enterococcus faecium	Gentamicin	Yes	Survival
22	Yes	staphylococcus haemolyticus	Vancomycin Amikacin	No	Died
23	Yes	S. epidermidis	Teicoplanin	No	Survival
24	Yes	ent.agglomerans	Imipenem Amikacin	No	Survival
25	Yes	klebsiella pneumoniae	Meropenem	No	Survival
26	Yes	S. aureus	Vancomycin	Yes	Survival
27	No	negtive	Vancomycin	No	Survival
28	Yes	acinetobacter baumannii	Imipenem Amikacin	No	Survival